QIAGEN NV (QGEN)
50.51
-0.04
(-0.08%)
USD |
NYSE |
Nov 10, 16:00
50.51
0.00 (0.00%)
After-Hours: 20:00
QIAGEN Cash from Operations (Annual) : 654.33M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 654.33M |
| December 31, 2024 | 673.55M |
| December 31, 2023 | 459.46M |
| December 31, 2022 | 715.26M |
| December 31, 2021 | 639.00M |
| December 31, 2020 | 457.81M |
| December 31, 2019 | 330.84M |
| December 31, 2018 | 359.50M |
| December 31, 2017 | 286.78M |
| December 31, 2016 | 341.60M |
| December 31, 2015 | 317.50M |
| December 31, 2014 | 295.46M |
| December 31, 2013 | 258.96M |
| December 31, 2012 | 244.88M |
| December 31, 2011 | 244.78M |
| December 31, 2010 | 250.75M |
| Date | Value |
|---|---|
| December 31, 2009 | 217.00M |
| December 31, 2008 | 173.00M |
| December 31, 2007 | 84.81M |
| December 31, 2006 | 101.48M |
| December 31, 2005 | 91.24M |
| December 31, 2004 | 53.80M |
| December 31, 2003 | 64.06M |
| December 31, 2002 | 36.69M |
| December 31, 2001 | 58.09M |
| December 31, 2000 | 38.87M |
| December 31, 1999 | 26.18M |
| December 31, 1998 | 22.91M |
| December 31, 1997 | 16.54M |
| December 31, 1996 | 6.991M |
| December 31, 1995 | 6.154M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Illumina, Inc. | 1.079B |
| Thermo Fisher Scientific, Inc. | 7.818B |
| Agilent Technologies, Inc. | 1.559B |
| Bio-Rad Laboratories, Inc. | 532.20M |
| Waters Corp. | 629.23M |